Compare · ELV vs NEUE
ELV vs NEUE
Side-by-side comparison of Elevance Health Inc. (ELV) and NeueHealth Inc. (NEUE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and NEUE operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV carries a market cap of $81.91B.
- Over the past year, ELV is up 32.0% and NEUE is down 0.1% - ELV leads by 32.1 points.
- ELV has hit the wire 6 times in the past 4 weeks while NEUE has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 0 for NEUE).
PerformanceELV-6.24%NEUE-0.15%
2026-05-19+0.00%2026-07-24
- Company
- Elevance Health Inc.
- NeueHealth Inc.
- Price
- $377.46-0.49%
- $6.84+2.09%
- Market cap
- $81.91B
- -
- 1M return
- -1.69%
- +2.09%
- 1Y return
- +32.00%
- -0.15%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 6
- 0
- Recent ratings
- 23
- 0
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest NEUE
- Chief Financial Officer Matushak Jay returned 40,431 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 15-12G filed by NeueHealth Inc.
- Large owner Bessemer Venture Partners Ix L.P. returned 999,218 shares to the company (SEC Form 4)
- Director Kraus Stephen returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)
- GC & Corporate Secretary Craig Jeffery Michael returned 20,103 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP, Consumer Care Orozco Tomas returned 29,325 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Sheehy Robert J returned 265,945 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Adkins Kedrick D Jr returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Kadre Manuel returned 33,505 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Slavitt Andrew M returned 107,809 shares to the company, closing all direct ownership in the company (SEC Form 4)